Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM.

Matheson, Elizabeth C., Thomas, Huw, Case, Marian, Blair, Helen, Jackson, Rosanna K., Masic, Dino, Veal, Gareth, Halsey, Chris, Newell, Herbie, Vormoor, Josef and Irving, Julie A.E. (2019) Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM. Haematologica, 104. pp. 1804-1811. ISSN 0390-6078

Abstract

epub ahead of print

Preview

PDF SURE 11055 B9D94670-ED51-4256-9855-D2603371FF22.pdf - Accepted Version Download (1MB) | Preview

More Information

Depositing User: Michelle Marshall

Identifiers

Item ID: 11055

Identification Number: 10.3324/haematol.2017.185975

ISSN: 0390-6078

URI: http://sure.sunderland.ac.uk/id/eprint/11055

Official URL: http://dx.doi.org/10.3324/haematol.2017.185975

Users with ORCIDS

Catalogue record

Date Deposited: 21 Aug 2019 15:28

Last Modified: 04 Jun 2025 17:25

Contributors

Author:	Elizabeth C. Matheson
Author:	Huw Thomas
Author:	Marian Case
Author:	Helen Blair
Author:	Rosanna K. Jackson
Author:	Dino Masic
Author:	Gareth Veal
Author:	Chris Halsey
Author:	Herbie Newell
Author:	Josef Vormoor
Author:	Julie A.E. Irving

University Divisions

Faculty of Health Sciences and Wellbeing

Actions (login required)

View Item (Repository Staff Only)